Monday, June 29, 2026

U.S. Targets $122.8B in Korean Exports as Section 301 Probe Puts Autos at Risk

The U.S. begins a Section 301 investigation into South Korea's overproduction in key export sectors, raising potential trade pressures.

Strengthening U.S.-Korea Nuclear Deterrence: Insights from the 6th NCG Meeting

The U.S. and South Korea held the sixth Nuclear Consultative Group meeting, focusing on nuclear integration and countering North Korea's threats.

North Korea’s Kim Yo-jong Condemns G7’s Denuclearization Claims: What This Means for Global Security

Kim Yo-jong condemned the G7's denuclearization demands, asserting North Korea's commitment to its nuclear arsenal as a deterrent.

Tag: L&K Biomed

L&K Biomed Reports First Human Use of BluEX-LT Spinal Implant at Major U.S. Hospital

L&K Biomed successfully completed the first surgery using its BluEX-LT implant, enhancing spinal deformity treatment and market expansion plans.

L&K BioMed Showcases Innovative Products at the AANS Conference in Texas

L&K BioMed showcased its products at the AANS conference, receiving positive feedback and interest for its cervical products, aiming to expand in the U.S. market.

Korean Spine-Implant Maker Targets Japan: L&K Biomed Showcases BluEX-LT at the Scoliosis Research Society Meeting

L&K Biomed showcased its products at the SRS conference in Japan, aiming to expand its market share in the APAC region, especially Japan.

Top News

- Our Sponsors Ad -

Follow us